Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ninjinyoeito for frailty in dialysis patients
jRCTs021200021Recruiting
- Sponsor
- Kracie
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ninjinyoeito in kidney failure and Fragility, sponsored by Kracie. Primary endpoint: Change in SNAQ score at 12 weeks. Started Sep 2020; status: recruiting.
02
Drugs
ninjinyoeito
03
Conditions
kidney failureFragility
Beyond the preview
Go deeper on jRCTs021200021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021200021.